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Cell Growth Measurement
Ning Xu, Xingrou Chen, Jingjing Rui, Yan Yu, Dongshi Gu, 
Jennifer Jin Ruan and Benfang Helen Ruan
Abstract
The cell is the basic structural and functional unit of all living organisms. As 
the smallest unit and building blocks of life, cells differ in size, shape, metabolism, 
reproduction, and growth requirements. Cells reproduce through cell division 
involving a four-phase (G1, S, G2, M) cell cycle, which is tightly regulated at mul-
tiple checkpoints. The resulting growth curve demonstrates that cell population 
increases in three sequential steps: incubation, exponential hyperplasia, and stagna-
tion/death phases. Cell growth is subject to changes in disease state and/or environ-
mental conditions. This chapter will focus on methods for cell growth measurement, 
which are grouped into five sections: cell cycle, apoptosis, growth curve, drug-
induced proliferation (DIP), and continuous assays. Among the continuous assays, 
the EZMTT dye allows for long-term tracking of cell growth under various condi-
tions and shows promise in precision medicine by early detection of drug resistance.
Keywords: cell cycle, apoptosis, growth curve, drug-induced proliferation, 
continuous assays, drug resistance
1. Introduction
The cell is the smallest unit of living organisms [1] and grows both in popula-
tion and size. Cellular growth [2] is tightly regulated and usually shows three 
sequential steps, including incubation, exponential hyperplasia, and stagnation/
death phases [3]. Unrestricted cell growth causes cancer, and drugs cure the disease 
by regulating the cell growth back to normal. Therefore, precise measurement 
of cell growth is very important in biomedicine, including cancer, aging, drug 
resistance, drug discovery, environment contamination, material biocompatibility 
[4, 5], fermentation, immunology, etc.
Cells grow by cell division which includes four major components: the G1, S, 
G2, and M phases in sequence [6], as shown in Figure 1. The signature of the G1 
phase is the synthesis of enzymes that are required for DNA replication. During 
the S phase, DNA is replicated to produce two identical sets of chromosomes. The 
G2 phase is mainly involved in the production of microtubules that are required 
during the process of division, the mitotic phase. Increases in cell volume are 
observed during the interphase (G1, S, G2 phase). The M phase consists of pro-
phase, metaphase, anaphase, and telophase in sequence, and the parent cell is 
divided into two daughter cells through nuclear division (karyokinesis), cytoplas-
mic division (cytokinesis), and formation of a new cell membrane [7].
Cell division is more complex in eukaryotes whose cell division involves either 
mitosis or a more complex process called meiosis. Mitosis and meiosis are two 
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different “nuclear division” processes. Through binary fission, mitosis [8] pro-
duces two daughter cells with the same number of chromosomes as the parental 
cell. Meiosis, also called reductive division, is the division of a germ cell involving 
two fissions of the nucleus to form four gametes that have half the normal cel-
lular amount of DNA. A male and a female gamete can then combine to produce a 
zygote, a cell which again has the normal number of chromosomes [9]. Therefore, 
the enlargement of cell volume and changes in DNA content are two parameters 
commonly used in cell cycle measurement.
The cell cycle is tightly regulated at multiple checkpoints [10]. Various growth 
conditions such as the temperature, nutrients, cell density, and drug treatment 
can block the cell cycle at various stages. Instead of unrestricted growth, the cell 
growth curve shows that the cell population increases through three phases: incuba-
tion period → exponential hyperplasia → stagnation period. During exponential 
growth, cells demonstrate great variation in required cell density and doubling 
times that are highly dependent on cell type and growth conditions.
Cell death occurs in each generation. Acute cellular injury causes traumatic cell 
death (necrosis) [11], whereas apoptosis is a highly regulated and programmed cell 
death that occurs each day in multicellular organisms. The average adult human 
loses between 50 and 70 billion cells each day due to apoptosis [12] which is critical, 
because uncontrolled cell proliferation is closely related to the occurrence of human 
diseases such as tumors. Commonly used analyses for apoptosis are morphological 
analysis, detection of apoptotic biomarkers, and flow cytometric analysis of cellular 
DNA content.
Inhibiting cancer cell or infectious microbial growth is the purpose of drug 
treatment. However, drug resistance is the notorious worldwide crisis that prolongs 
hospital stays and considerably increases mortality. Identification of specific genetic 
mutations has been the major effort in understanding drug resistance, but the 
Figure 1. 
Cell cycle.
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results have had little diagnostic value [13]. Recently, many research groups [14–17] 
demonstrated that drug resistance develops owing to a small population of cells 
resistant to the drug, and drug treatment results in the selection for the growth of 
the small drug-resistant cell population. Recognition of partial efficacy is, there-
fore, very important in early detection of drug resistance.
Traditionally, the dose–response curve is used to evaluate the potency of an 
inhibitor (IC50). Commonly used cell proliferation assays are metabolic activity-
based methods such as the tetrazo-based cellular NAD(P)H detection system (MTT, 
CCK8, EZMTT) and the cellular ATP detection system (CellTiter-Glo Assay). 
Unfortunately, due to experimental error, the endpoint assays are not sensitive 
enough to detect the survival of a minor population of cells.
For precise measurement of drug efficacy, the drug-induced proliferation (DIP) 
rate has been proposed as a better parameter than the IC50 or MIC (80% inhibi-
tion) measurement [15]. However, the measurement of a precise DIP rate calls for 
continuous assays that can be used easily with various cell types.
Therefore, this chapter will mainly discuss the methods used for measuring cell 
cycle, apoptosis, growth curve, and drug-induced proliferation, continuous assays 
that can track the growth condition-induced cell proliferation, and its applications 
in early discovery of drug resistance.
2. Cell cycle
Each cell cycle involves the G1, S, G2, and M phases in sequence, and each 
phase is associated with its signature protein biomarkers, DNA content, and 
cell size, as shown in Figure 1. DNA ploidy and protein biomarker analyses are 
commonly used in cell cycle studies and have important applications in clinical 
cancer diagnosis, drug efficacy evaluation, prognosis prediction, cell dynamics, 
and apoptosis.
2.1 Parameters used for DNA content analysis
DNA ploidy, DNA index (DI), S phase fraction (SPF), and potential doubling 
time (Tpot) are commonly used parameters for cell cycle analyses.
DNA ploidy refers to the number of chromosomes or the total DNA content in 
cells. DNA ploidy analysis in combination with clinical pathological diagnosis has a 
great value in early diagnosis and in prognosis prediction for malignant tumors, for 
both solid tumors and cancer cell extracts from body fluids, glandular secretions, 
and exfoliated tissue cells. Aneuploid tumors showed significantly higher recurrent 
rates than the diploid ones [18].
The DNA index (DI) refers to the ratio between the cells in G0/G1 peak of the 
tumor samples and that of the normal diploid samples. The calculation equation 
is DI (DNA index, number of judgment ploidy) = (average number of G0/G1 
phase cell peaks in sample)/(average number of G0/G1 phase cell peaks in normal 
diploid cells). A DI of 1 means a normal diploid sample (generally the normal 
range is 0.9 to 1.1) [19].
The S phase fraction (SPF) shows the percentage of cells in S phase and indi-
cates the proliferative activity of the cells. The calculation equation is SPF (S phase 
fraction %) = S cells / (G0/G1 + S + G2M) cells × 100%. Another cell proliferation 
parameter is proliferation index (PI), and the calculation equation is PI (prolifera-
tion index %) = (S + G2M) cells/ (G0/G1 + S + G2M) cells × 100%.
The potential doubling time (Tpot) refers to the time required to double the cell 
number, which occurs during exponential growth.
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2.2 DNA content analysis
DNA content can be analyzed after fluorescent staining or labeled nucleic acid 
incorporation as shown in Table 1.
As shown in Figure 2, DAPI and Hoechst dyes penetrate the membrane and 
are commonly used to label live cells, whereas propidium iodide (PI), propidium 
monoazide (PMA), and ethidium bromide monoazide (EMA) only label dead cells. 
Newly synthesized DNA in active proliferating cells can be labeled by the radiola-
beled 3HTdR, 125IUdR [24], or the fluorescent-labeled BrdU and EDU [25].
Flow cytometry measurement (FCM) is a sensitive method to measure cell size 
and fluorescent labeling. Double staining both cellular DNA and protein biomarker 
allows identification of cells in G1 peaks, G2+ M peaks, and S platforms, as well 
as the subdiploid peaks (apoptotic peaks) before the G1 peak. These methods in 
combination with other biomarkers show the distribution of cells in each phase of 
the cell cycle and can be used to investigate cell dynamics [26].
2.3 Protein biomarkers
Proteins that are found in proliferating cells, but not in nonproliferating cells 
can be used as biomarkers for cell cycle measurement. Ki-67 protein (also known as 
MKI67) is present during all active phases of the cell cycle (G1, S, G2, and mitosis) 
but is absent in resting (quiescent) cells (G0) [27]. During interphase, the Ki-67 
protein is exclusively located in the cell nucleus, whereas in mitosis most of the pro-
tein is relocated to the surface of the chromosomes. During cell progression through 
S phase of the cell cycle, the Ki-67 protein markedly increases [28]. As shown in 
Figure 1, the fluorescent-labeled monoclonal Ki-67 antibody has been used for cell 
cycle measurement and cancer diagnosis. Other commonly used cell proliferation 
biomarkers include proliferating cell nuclear antigen PCNA [29], topoisomerase IIB 
[30], and phosphorylated histone H3 [31].
DNA stain Principle Membrane 
permeability
Function
4′,6-diamidino-2-
phenylindole (DAPI)
Binds to DNA A-T rich region [20] Yes Live cell
Hoechst dye Binds to DNA A-T rich region [21] Yes Live cell
Propidium Iodide (PI) Label dead cells [22] No Dead cell
Propylene glycol 
monomethyl ether 
acetate (PGMEA)
In combination with dsDNA to form 
a stable and strong covalent nitrogen-
carbon bond [23]
No Dead cell
Ethidium bromide 
monoazide (EMA)
Covalent cross-linking with genomic 
DNA [23]
No Dead cell
3 HTdR incorporation 3H-TdR incorporates in DNA synthesis Yes Live cell
125IUdR incorporation 125IUdR incorporates in DNA synthesis Yes Live cell
BrdU incorporation Brdu participates in DNA synthesis in 
cell proliferation
Yes Live cell
EDU incorporation EDU participates in DNA synthesis in 
cell proliferation
Yes Live cell
Table 1. 
Comparison of methods for DNA labeling.
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3. Apoptosis
Apoptosis is a programmed cell death, and the process involves a series of 
morphological changes such as blebbing, cell shrinkage, nuclear fragmentation, 
chromatin condensation, as well as biochemical changes such as chromosomal DNA 
fragmentation, global mRNA decay [32], and appearance of protein biomarkers in 
protein degradation pathways.
Commonly used analyses include transmission electron microscopy for morpho-
logical analysis, biochemical assays for detection of apoptotic biomarkers, and flow 
cytometry analysis of cellular DNA content (Figure 3).
3.1 Transmission electron microscopic analysis
Tissue or cells can be directly stained using dyes such as hematoxylin, methyl 
green pyronine, and acridine orange for microscopic analysis. Under the trans-
mission electron microscope [33], apoptotic cells show reduced size and more 
concentrated cytoplasm. In the nucleus of pro-apoptosis phase, the chromatin is 
highly coiled, and many vacuole structures called cavitation appear; in the phase 
IIa nucleus, the chromatin is highly coagulated and marginalized; in the end, the 
nucleus is cleaved into fragments and produces apoptotic bodies. Fluorescence 
microscopy and confocal laser scanning microscopy [34] can also be used to observe 
the progress of apoptosis, based on morphological changes of nuclear chromatin 
DNA-specific dyes such as Hoechst dye series and DAPI.
3.2 TUNEL method
The TUNEL assay [35] distinguishes between normal and apoptotic cells based 
on the amount of FITC-dUTP incorporation into the broken DNA ends in the intact 
single apoptotic nuclei or apoptotic bodies, whereas the normal or growing cells 
have almost no DNA breaks and will not be stained. This method accurately reflects 
the most typical biochemical and morphological features of apoptosis and can used 
with paraffin-embedded tissue sections, frozen tissue sections, cultured cells, and 
tissue-separated cells. The method is simple, easy, and sensitive in detecting a very 
small amount of apoptotic cells.
Figure 2. 
Methods for DNA analysis in both live and dead cells.
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The limitations of the TUNEL method are as follows. Firstly, it labels apoptotic 
cells only in the middle and late stages. Secondly, necrotic cells also contain DNA 
breaks and are labeled by dUTP, so the assay is not specific enough to distinguish 
between apoptotic and necrotic cells. Thirdly, cells need to be fixed during the 
labeling process, which may lead to excessive cell debris or loss of DNA frag-
ments. Lastly, subjective factors are involved when counting the number of the 
apoptotic cells.
In addition, agarose gel electrophoresis can be used to detect the apoptotic DNA 
fragmentation into an integer multiple of 180–200 bp [36]. ELISA can be performed 
using anti-DNA and anti-histone monoclonal antibody to detect nucleosome frag-
ments [37]. Mitochondrial membrane potential measurement can distinguish early 
apoptosis [38] and provides a nice complement to the TUNNEL method.
3.3 Fluorescent staining for flow cytometry analysis
Application of annexin V is a widely used method for detecting apoptosis 
[39]. Annexin V is a Ca2 + −dependent phospholipid binding protein with a 
molecular weight of 35–36KD, which can bind with phosphatidylserine with high 
Figure 3. 
Methods in measuring apoptosis: (A) lymphocytes stained with EB/AO solution. Triangle, arrow, and 
arrowhead show viable, early apoptotic and late apoptotic cells, respectively. (B) Transmission electron 
image of a broken apoptotic lymphocyte. The cell breaks up into apoptotic bodies containing organelles or 
the condensed nuclear fragments. (C) Scanning electron image of a macrophage phagocytosing the apoptotic 
lymphocytes (asterisks). (D) A macrophage engulfing an apoptotic lymphocyte L, containing the condensed 
nuclear fragments. Arrows show phagosomes containing the apoptotic bodies of lymphocytes. (E, F) A 
macrophage phagocytosing apoptotic cells. (G–J) LC3 fluorescent stain in macrophages phagocytosing the 
apoptotic lymphocytes. The nuclei were stained with DAPI (G) or PI (H). (K and L) PI staining was used to 
evaluate the apoptosis.
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affinity. Annexin V can be labeled with fluorescein isothiocyanate (FITC, PE) or 
biotin and used as a fluorescent probe to detect apoptosis by flow cytometry or 
fluorescence microscopy.
PI dye does not pass through the intact cell membrane, but in the middle and late 
stages of apoptosis, PI can pass through the cell membrane to bind to the DNA and 
redden the nucleus [40, 41]. PI staining of the apoptotic cells shows a subdiploid 
peak (Ap peak) that appears before the G1 peak. The number of apoptotic cells can 
be detected based on the level of the Ap peak. Therefore, combining results from 
both annexin V staining and PI staining, cells in the early and late stage of apoptosis 
and necrosis can be distinguished.
However, the limitation of both staining methods is the poor sensitivity. It 
is difficult to detect DNA fragments in early apoptotic cells and easy to miss the 
detection of apoptotic cells in S phase or G2/M phase. Meanwhile, the PI method is 
partially necrotic, and the cellular debris could cause false detection.
Additional methods are detecting the release cytochrome C from mitochondria 
into cytoplasm during apoptosis [42], as well as activation of signaling pathways 
involving caspase 3, caspase 9, Apaf-1, PARP, Bcl2, Akt, TFAR19, etc., to differenti-
ate the exogenous or endogenous cause of cell apoptosis [43].
3.4 Double or multiple staining
To distinguish the apoptotic cells, necrotic cells, and living cells, research-
ers perform flow cytometric analysis after double staining with annexin V and 
PI. Annexin V-FITC has poor membrane permeability and can specifically bind 
phosphatidylserine; for live cells, no phosphatidylserine can be detected by annexin 
V, but during apoptosis, phosphatidylserine is valgus outward to the outer side of 
the cell membrane for easy detection. The fluorescent dye PI binds to chromatin 
but does not enter the cytoplasm of live cells. However, PI can enter the apoptotic 
cells and necrotic cells and effectively stain the concentrated chromatin in apoptotic 
cells. In addition, for low PI-stained cells, H0342 dye can be used for detection of 
apoptotic cells with concentrated chromatin. H0342 stain enters cells with intact 
membranes and stains apoptotic cells more strongly than normal cells. When used 
in combination with forward scatter (FSC) and side scatter (SSC), H0342 staining 
can distinguish apoptosis from living cells [44].
Taken together, the FCM method requires less sample, provides high sensitiv-
ity, and simultaneously analyzes apoptotic cells and normal cells. Morphological 
observation can be carried out using an optical microscope, and electron micros-
copy is an authoritative method, which is commonly used before serious quantita-
tive analysis. Agarose gel electrophoresis can also be used as a qualitative analysis, 
but the results need further confirmation by TUNNEL technology or annexin-V/PI 
dual-label method.
4. Cell proliferation
Cell growth (proliferation) can be evaluated by the time-dependent changes 
of the total number of proliferating cells, as well as the ratio of cells among 
individual phases of the cell cycle. The cell growth curve was plotted to show the 
time-dependent increase in cell numbers. Depending on the cell type and growth 
condition, the required cell density to enter the exponential phase and the rate of 
cell growth measured by the doubling time (Tpot) could be very different. For 
example, most microbials (e.g., E. coli) enter the exponential growth phase with low 
cell numbers and show fast growth rate with a doubling time less than an hour [45], 
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whereas M. tuberculosis and mammalian cells have longer doubling time of several 
hours or a day. The growth and reproduction of cells can be further altered by 
changes in temperature, nutrition, viral infection, and/or the presence or absence 
of inhibitors [46]. Therefore, the growth curve is important in guiding clinical drug 
usage, investigating gene functions, and understanding drug mechanism of action. 
Various methods have been developed to measure the absolute number of cells or 
the changes in cell number, as shown in Figure 4.
4.1 Manual cell counting
Traditionally, cell numbers are counted by taking an aliquot of a homogenous 
cell suspension and plating on a hemocytometer to count the numbers under a light 
microscope. The obtained cell number in a certain volume of the suspension is then 
converted into the cell concentration (cells per ml) in the stock solution. Bacteria 
are counted by a Petroff-Hausser bacterial counter, a Hawksley counter, and/or 
the plate colony formation method. The plate colony counting method often gives 
a lower cell number than the actual value, because it is often difficult to disperse 
bacteria into a single cell and to make sure that a single colony is not derived from 
several bacteria.
4.2 Automated mechanical counting
The most commonly used automatic cell counting methods are direct electri-
cal impedance, flow cytometry, computer-aided image analysis, and serological 
counting. Through changes in electrical properties, the direct electrical impedance 
method quantifies the number and the volume of cells in the blood. Using a photo-
multiplier to filter and detect the signal, flow cytometry records both the density 
and height of fluorescent pulses and then converts them to the number of bacteria; 
the method is fast and sensitive and can simultaneously analyze the cell morphol-
ogy and protein biomarkers. Computer-aided image analysis [47] and serology [48] 
counting methods analyze the image or 2D picture to obtain accurate quantification 
and morphological structure. So far, both methods have been used successfully in 
biology, materials science, mineralogy, and neurological science.
Figure 4. 
The main methods for cell growth measurement.
9Cell Growth Measurement
DOI: http://dx.doi.org/10.5772/intechopen.86835
4.3 Indirect cell counting methods
4.3.1 Turbidity assay by spectrophotometry
Turbidity can be observed when the cell density reaches certain level; within a 
certain range, the number of cells is proportional to the turbidity of the bacterial 
culture. The cell turbidity is measured by a spectrophotometer or a colorimeter, 
and a standard curve is generated by plotting the absorbance at OD600nm and the 
actual cell numbers in the sample. Photoelectric turbidimetric counting is a simple, 
rapid, and continuous measurement suitable for high-throughput screening. 
However, its optical density is less sensitive, cannot differentiate between dead or 
live bacteria, and is greatly affected by cell size, morphology, and the color of the 
culture solution [49].
4.3.2 BACTEC MGIT method
BACTEC MGIT [50, 51] measures microbial growth by oxygen depletion which 
requires anaerobic conditions, so the bacteria must be grown in a sealed tube or 
compartment. This method has been widely applied in medical diagnosis but is not 
suitable for high-throughput plate-based AST assays.
4.3.3 Fluorescent dye method
Live or dead cells that cannot be differentiated by the light microscope can be 
counted after fluorescent labeling. Table 2 showed the commonly used dyes that 
Fluorescent dye Stain 
subject
Membrane 
permeability
Excitation/
emission 
wavelength
Function Detection
SYTO nucleic 
acid stains
Nucleic 
acid [52]
Yes 420~657/441~678 Live or 
dead cell
Fungus, 
bacteria
SYTOX green 
nucleic acid 
stain
Nucleic 
acid [53]
No ~504/~523 Dead cell Fungus, 
bacteria
Propidium 
iodide (PI)
Nucleic 
acid [54]
No ~530/~635 Dead cell Fungus, 
bacteria, 
mammals
Sulforhodamine 
B (SRB)
Protein 
[55]
Yes ~565/~586 Live cell Mammals
PHK26, 67 Membrane 
[56]
Yes ~551/~567, 
~496/~520
Live cell Mammals
DiO Membrane 
[57]
Yes 482~487/ 501~504 Dead cell Mammals
DiD Membrane 
[58]
Yes ~646/~665 Dead cell Mammals
Calcofluor white 
M2R
Cytoderm 
[59]
Yes 385~405/ 437~445 Live cell Fungus
DiBAC4(3) Membrane 
[60]
Yes 506/ 526 Dead cell Fungus, 
bacteria, 
mammals
Table 2. 
Summary of fluorescent dye.
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label the cellular components such as nucleic acid, cytoplasm, cell membrane, redox 
environment, and lipase. For example, SYTO series nucleic acid fluorescent dyes, 
etc. stain the DNA or RNA of the live or dead cells; PI nor SYTOX Green nucleic 
acid dyes cannot transfer into the live cells and stain the DNA of the damaged cell 
membranes. Both types of dyes can be used in combination to measure the ratio 
of live and dead cells. After labeling, the cells can be detected by a fluorescence 
microscopy or by a flow cytometry. The combination of fluorescent dyes and 
advanced instruments makes it possible to realize the “visualization” and investi-
gate the mechanisms of action under the physiological and pathological conditions 
and to explain the significance of life effects, which is of great significance in the 
field of disease diagnosis and drug screening.
5. Drug-induced proliferation assays
A drug is a substance that induces functional changes in an organism through 
chemical or physical actions, regardless of whether the resulting effect is beneficial 
or detrimental to the health of the receiving organism. Therefore, assays are critical 
in revealing interactions between the drug and the organism. In particular, the cell 
proliferation assays provide valuable information for exploring the pathogenesis of 
the disease, diagnosing the disease, and treating the disease.
Traditionally, a dose–response curve is used to evaluate the potency of an 
inhibitor (IC50). The commonly used cell proliferation assays are either metabolic 
activity-based methods such as the tetrazo-based cellular NAD(P)H detection 
system (MTT, CCK8 method) or the cellular ATP detection system (CellTiter-Glo 
Assay). According to the mechanism of metabolic activity detection, these endpoint 
colorimetric and fluorescence methods can be divided into five categories (Table 3): 
the reducing environment of live cells, ATP of live cells, detecting products released 
by dead cells, esterase, and detecting mitochondrial metabolism of live cells.
5.1 Reducing environment of live cells
Resazurin and its derivative C12-resazurin are not fluorescent, but their reduced 
forms are fluorescent. Dehydrogenase reduces the non-fluorescent blue resazurin 
into a strongly fluorescent pink resorufin [61] in enzyme- or cell-based assays. 
Since the dehydrogenase level is high in active cells and very low in damaged or 
inactive cells, the resazurin assay shows a strong signal in metabolically active cells. 
Interestingly, even though resazurin can be reduced by mitochondrial enzymes, no 
evidence of resazurin reduction was found in mitochondria as shown by confocal 
microscopy analysis [62].
Resazurin is water-soluble and stable in culture medium. Single reagent addition 
allowed for simple assays of cell viability which is especially suitable for automated 
manipulation and high-throughput analysis [63]. However, the fluorescence is 
bleached by light, so it is not suitable to track the cell growth.
5.2 ATP production in live cells
Adenosine triphosphate (ATP) is an indicator of active live cells, and its cellular 
level directly reflects the number and state of cells. The CellTiter-Glo method is a 
luminescence-based endpoint assay, commonly used for ATP measurement after 
cell lysis. The assay is based on ATP consumption by luciferase to produce light 
(maximum emission wavelength ~560 nm at pH 7.8) [64]. Due to the absence of 
interference of endogenous luciferase in mammalian cells, a stable glow-type signal 
11
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generated using luciferase can be detected as little as 0.1 picomoles ATP by lumi-
nometers, showing high sensitivity, although the signal decreases after 10–30 min.
The luciferin-luciferase bioluminescence assay has been used to detect small 
amount of bacterial contamination in samples such as blood, milk, urine, soil, and 
sludge [65]. In addition, the assay can evaluate antibiotic effects, determine cell 
proliferation and cytotoxicity in both bacterial and mammalian cells [64], and 
distinguish the cytostatic and killing potential of anticancer drugs for malignant cell 
growth. Furthermore, it has been used for bioactive factor activity assays, large-scale 
antitumor drug screening, cytotoxicity assays, and tumor radiosensitivity assays.
5.3 Lactonase in living cells
Lactonase is a non-specific esterase and cleaves a non-fluorescent molecular 
probe to produce a fluorescent substance. Lactonase activity is high in live cells but 
low in dead cells, so the fluorescence is seen and retained in live cells. In addition, 
the fluorescence can be evenly distributed to the two daughter cells after cell divi-
sion, although each successive passage decreased the fluorescence intensity in cells 
by 50% as analyzed by flow cytometry [66].
The most commonly used fluorescent probes are fluorescein diacetate (FDA) 
and its derivative succinimidyl ester of carboxyfluorescein diacetate, commonly 
known as CFSE-SE [67]. CFDA-SE was initially used for lymphocyte proliferation 
testing in 1994 and then applied to detect monocytes, fibroblasts, etc. The CFDA-SE 
method determines the cycle number of cell divisions based on fluorescence inten-
sity. Also, it can be used to trace in vivo studies [68, 69].
In addition, calcein-AM, (3′,6′-Di(O-acetyl)-4′,5′-bis[N,N-bis(carboxymethyl) 
aminomethyl] fluorescin tetraacetoxymethyl ester), also known as calcein acetyl 
Classification Method Description Cell 
viability
Application
Reducing 
environment of 
live cells
Resazurin Reduced by cytosolic 
dehydrogenase in 
metabolically active cells 
to produce pink strong 
fluorescent resorufin
Live cells Growth
ATP production 
in live cells
CellTiter-Glo Luciferase consumes ATP  
to produce light
Lysed 
cells
Growth
Esterase of live 
cells
FDA;calcein-AM Cleaved by esterase in 
living cells to produce 
a fluorescent substance 
retained in the cell
Live cells Division
Released 
products of dead 
cells
LDH release LDH released by damaged 
or dead cells reduces the 
tetrazolium salts to colored 
formazan
Dead cells Death
51Cr release 51Cr released by damaged 
or dead cells can be 
measured by a radioactivity 
assay
Dead cells Death
Mitochondrial 
dehydrogenase of 
live cells
Tetrazolium Reduced by mitochondrial 
dehydrogenase to produce 
colored formazan products
Live cells Growth
Table 3. 
Comparison of commonly used methods for drug-induced proliferation assays.
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ester, is a fat-soluble substance and membrane-permeable fluorescein dye [70]. 
It is non-fluorescent and freely enters the cytoplasm and organelles such as the 
mitochondrial matrix. Upon entry, calcein-AM can be hydrolyzed by intracellular 
esterase to produce water-soluble calcein (calcium chlorophyll), which remains 
in the cytosol and mitochondrial matrix and produces strong green fluorescence 
under 494 mm excitation light.
5.4 Released products from dead cells
The radioisotope chromium (51Cr) release method was initially developed to 
detect dead cells and has now gradually been replaced by the LDH release method. 
Due to increased membrane permeability, the damaged or dying cells release the 
cytosolic LDH in cell culture medium [71], so the LDH activity is proportional 
to the number of dead cells. The LDH release assay has been used to measure the 
activity of cytotoxic lymphocyte (CTL) and natural killer (NK) cells, as well as the 
cytotoxicity caused by drugs, chemicals, or radiation.
5.5 NADH and NADPH production of live cell
NADH and NADPH are important biological cofactors for enzymes that are fun-
damental for various biological processes, such as energy metabolism, mitochondrial 
function, oxidative stress, immunological functions, and cell death [72]. Antioxidant 
drugs that could change cellular NAD(P)H concentrations have been effective in diseases 
such as aging, inflammation, neural degeneration, and cancer [73, 74]. Many tetrazolium 
compounds can be reduced by NADH and NADPH to produce colored formazin and 
have been developed commercially for cell vitality assay, as shown in Table 4 [75].
Triphenyl tetrazolium chloride (TTC) is a lipophilic and light-sensitive com-
pound, and the TTC assay was developed back in 1894 for seed viability tests and is 
currently a traditional method for brain live-dead neuron evaluation after ischemic 
stroke [76]. MTT is the most commonly used reagent for cell proliferation or cell 
toxicity assays, but its formazan is water-insoluble and requires an additional DMSO 
solubilization step for its quantification at 540 nm [77]. WST-8 is a water-soluble 
tetrazolium salt, and its brown-colored formazan can be measured directly by UV 
absorbance at 450 nm. Because of its simple protocol, the WST-8 (CCK-8) assay has 
become a popular cell vitality method [78–80]. However, WST-8 is not very stable 
especially under the reduced condition, so EZMTT was developed for drug-induced 
proliferation assay [81]. EZMTT is another water-soluble tetrazolium salt which is 
Tetrazolium Structural 
formula
Solubility 
(tetrazolium/
formazin)
Color 
(tetrazolium/
formazin)
Cytotoxicity Reagent 
stability
MTT a Soluble/insoluble Yellow/purple ** **
XTT e Soluble/soluble Yellow/orange **** ****
MTS i Soluble/soluble Yellow/purple ** ****
WST-1 l Soluble/soluble Yellow/orange * ****
CCK-8/WST-8 t Soluble/soluble Yellow /orange
OD 450 nm
* ***
EZMTT o Soluble/soluble Yellow/orange
OD 450 nm
Essentially 
nontoxic
**
*less ***** the most
Table 4. 
Comparison of MTT, XTT, MTS, WST-1, CCK-8, and EZMTT.
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less toxic than also, EZMTT reagent showed excellent stability and signal of back-
ground ratio. Effort has been made to develop the EZMTT to greatly enhance the 
sensitivity and precision of the drug-induced proliferation assay.
In summary, these cell metabolism-based assays are commonly used as end-
point assays for IC50 measurement to rank the potency of a drug. However, the 
world crisis in drug resistance in infectious disease and cancer called for a deeper 
look at the drug-induced proliferation assays. Since drug resistance develops 
owing to a small fraction of the cell population that is resistant to the drug, a sen-
sitive method for detecting partial drug resistance is very important in prevent-
ing the occurrence of drug resistance. Another approach is to measure not only 
the drug potency by IC50 values but also the drug efficacy by the drug-induced 
proliferation rate (DIP) [15]. However, to minimize the experimental error in 
detecting minor growth, precise DIP rate measurement in HTS mode requires 
the availability of a continuous assay that can track the cell proliferation from the 
same samples.
6. Continuous assay
Continuously tracking the cell growth is important for accurate assessment of 
drug effects and/or growth condition changes. Even though various endpoint assays 
[75, 82, 83] can be terminated at various time point to obtain the time-dependent 
cell proliferation curve, the procedures are labor-intensive and have high experi-
mental error. Therefore, a nondestructive continuous assay is highly desirable 
and critical for the precise evaluation of drug potency and efficacy. Besides the 
traditional turbidimetric assay by spectrophotometry that has been used for years 
in microbial assays, four new technologies have been developed that can be used for 
continuous assays.
6.1 High-content analysis
High-content analysis is a cell imaging and analysis system which includes 
automatic high-speed microscopic imaging, fully automatic image analysis, and 
data management. Through snapshot cellular microscopic imaging of a 96-well 
plate followed by synchronous analysis, the high-content analysis, such as the 
CloneSelectTM imaging system, accurately measures the cell number without any 
cell damage. Compared with the MTT method, the experimental deviation of dose 
pharmacodynamic curve obtained by CloneSelectTM imaging system is smaller 
and more reproducible. Therefore, high-content analysis has become a reliable 
choice for big pharmaceutical companies to evaluate drug antiproliferation effects 
in high-throughput screening, although mostly for attached mammalian cells.
6.2 Electrical impedance technology
Electrical impedance technology-based real-time cellular analysis (RTCA) 
[84–86] and Epic BenchTop optical biosensors methods [87, 88] have been used 
in measuring bacterial growth. However, the methods require cells to be cultured 
on the working electrode or a sensor array of complex structures. The methods 
[89] cannot detect changes in the cells themselves, so the cell damage caused 
by drugs and the understanding of the mechanism of drug action are difficult 
to assess accurately; this inevitably brings detection error and interference. In 
addition, the requirement of complex laboratory infrastructure further limits 
their utility.
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6.3 Raman spectroscopy analysis
Raman spectroscopy provides a spectroscopic fingerprint of a substance. 
Based on the difference in monochromatic light with vibrational modes, Raman 
spectroscopy can be used for qualitative and quantitative measures of the changes 
in biochemical composition. For example, Raman spectroscopy was used as a 
noninvasive method to distinguish cells at different stages in the cell cycle [90]; to 
identify living cells from dead cells [91–95]; to image cellular organelles [96]; to 
track drug distribution [97] and metabolism [91]; to monitor cell apoptosis [94], 
death, and cytotoxicity [92, 95]; and to study cell responses to external stimuli 
[97–101]. However, the analysis of Raman results requires expertise in identifying 
the spectroscopic fingerprint of a substance.
6.4 EZMTT dye-based cell proliferation analysis
The EZMTT dye [81] was initially designed to overcome the stability issue 
of WST-8 (CCK-8) reagent which can cause false positives in the presence of 
antioxidants such as BME (Figure 5A) or EGCG. Later, the EZMTT dye was 
found to be essentially nontoxic and stable in various media [102]. After a single 
dye addition (Figure 5B), the EZMTT method showed linear dose–response to 
cell numbers and higher signal to background ratio than other relevant methods 
(Figure 5C). The IC50 values measured by the EZMTT method are precise and 
essentially the same as the other methods (Figure 5D). Interestingly, when 
both EZMTT and WST-8 (CCK-8) methods were applied to track the growth of 
Figure 5. 
EZMTT assays: (A) EZMTT dye is stable in the presence of up to 6 mM BME. (B) One step addition of the 
EZMTT dye allows sensitive measurement of cell growth. (C) Comparison of the signal to background ratio of 
various tetrazo-based assay (MTS, MTT, CCK-8, EZMTT) in the presence of the same amount of A549 cancer 
cells. (D) Essentially the same IC50 values were obtained from the MTS, MTT, CCK-8, or EZMTT-based 
assays. (E) Cell growth followed by the EZMTT method. (F) Cell growth followed by the WST-8 method. 
(G) For a good inhibitor, essentially the same IC50 values were obtained from the CTG or EZMTT-based assays. 
(H) CB839 could only achieve up to 80% inhibtion; (I) the DIP rate of CB839.
15
Cell Growth Measurement
DOI: http://dx.doi.org/10.5772/intechopen.86835
A549 lung cancer cells, WST-8 (CCK-8)-treated cells stopped growth in 1 day, 
whereas the EZMTT-treated cells could grow till saturation (Figure 5E and F) 
and allowed easy determination of the cell density and the doubling time in the 
exponential phase.
In addition, when the EZMTT method was used to track the drug-induced 
proliferation (DIP) rate changes, the EZMTT method demonstrated high sen-
sitivity and reliability in detecting drug resistance. Figure 5H and I compares 
the dose–response curve obtained by the CellTiter-Glo (CTG) method and the 
EZMTT method. For a sensitive inhibitor, both methods showed essentially the 
same IC50 and % inhibition (Figure 5H). When a partial inhibitor is tested, both 
methods showed essentially the same EC50 values, but % inhibition was lower 
in the EZMTT method, because the partially inhibited cells are still growing 
(Figure 5I). Recently, several KGA allosteric inhibitors were rediscovered as 
partial inhibitors. For example, CB839 had shown 100% inhibition in CTG assay 
[103], whereas the EZMTT assay showed approximately 80% inhibition [104], 
and this is further confirmed by the (DIP) rate measurement. At the steady state, 
10 μM CB839 did not completely inhibit cancer cell growth. Interestingly, when 
64 nM CB839 and 24 μM ebselen were used in combination, synergistic effects 
were observed; even though individual compounds only showed partial inhibi-
tion, when used in combination, nearly complete inhibition of cancer cell growth 
was observed [105].
As a new assay format, EZMTT showed powerful applications in cell growth 
analysis, clinical diagnosis of trivial drug resistance, precise medicine for drug com-
bination, and cost-effective drug discovery by building better correlation between 
the in vitro cell-based assay and in vivo animal models.
7. Conclusions
Cell proliferation assays are widely used in molecular biology, tumor biology, 
pharmacology, and pharmacokinetics. It is important in studying not only the 
basic biological characteristics of cells but also a basic method for analyzing cell 
states and studying genetic traits. The increase of cell numbers can be simply 
measured by manual counting of cells under microscopy, using the dye exclusion 
method (i.e., trypan blue) to count only viable cells. Less fastidious, scalable 
methods include the use of cytometers; especially the flow cytometry allows 
combining cell counts (“events”) with other specific parameters such as fluores-
cent probes for membranes, cytoplasm, or nuclei which allows distinguishing 
dead/viable cells, cell types, cell differentiation, and expression of a biomarker 
such as Ki67. Beside counting the increasing number of cells, cells can also be 
assessed based on the metabolic activity, such as the CFDA-SE or calcein-AM 
method measures not only the membrane functionality (dye retention) but also 
the functionality of cytoplasmic enzymes (esterases). Also, the MTT-type assays 
or the resazurin assay (fluorimetric) measures the mitochondrial redox poten-
tial. Most of these assays are endpoint assays and may or may not correlate well 
with the cell proliferation, depending on cell growth conditions, populations of 
different cells, drug interferences, or toxicity. For precise evaluation of drug-
induced proliferation rate changes, a continuous assay is highly desirable. Among 
various assay formats, the EZMTT dye showed initial promise in precise and 
sensitive detection of partial inhibition which is the cause of worldwide crisis in 
drug resistance, and the EZMTT method is expected to provide valuable infor-
mation for exploring the pathogenesis of the disease, diagnosing the disease, and 
treating the disease.
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